Afficher la couverture 'Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye! | Maria, Alexandre T.J.' en grand format
/5

0 avis

Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye!

Archive ouverte

Maria, Alexandre T.J. | Delmas, Clement | Coustal, Cyrille | Palassin, Pascale | Roubille, François

Edité par CCSD ; Elsevier -

International audience. The Immune checkpoint blockers (ICB) have greatly improved clinical outcomes in multiple cancer types and are increasingly being used in earlier disease settings alone or in combination with other therapies. However, rare but life-threatening complications defined as immune-related adverse events (irAE) as ICI-induced myocarditis can occur, justifying close monitoring and specific management

Suggestions

Du même auteur

Auto-inflammatory reaction triggered by Nivolumab: A case of adult-onset Still's disease-like syndrome. Réaction auto-inflammatoire type maladie de Still induite par le nivolumab

Archive ouverte | Hermabessière, Stéphanie | CCSD

International audience. Case report . Lettre à la rédaction

Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis

Archive ouverte | Coustal, Cyrille | CCSD

International audience

Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys

Archive ouverte | Palassin, Pascale | CCSD

International audience

Chargement des enrichissements...